Top Header Mobile

Updates

Contact

 Session Chair Profile

img-Razelle _Kurzrock

PMWC PIONEER AWARD
Pioneering precision medicine clinical trials & studies in the US and around the world, and the use of liquid biopsy to predict immunotherapy

M.D., FACP, Center Associate Director, Professor, Medical College of Wisconsin

Razelle Kurzrock

Biography
 Dr. Kurzrock is a board-certified medical oncologist and a renowned expert in precision medicine. She is known for developing one of the largest and best known Phase I clinical trial programs in the United States while at MD Anderson Cancer Center in Texas. Dr. Kurzrock established the UCSD’s Center for Personalized Cancer Therapy at the Moores Cancer Center. The center focuses on genomically-driven therapy as well as precision immunotherapy, especially in rare cancers. Dr. Kurzrock is a global leader in personalized medicine, bringing the first transcriptomic study to the clinic in an international setting spanning five countries (WINTHER), as well as the first study of individually customized combination therapy (IPREDICT). Dr. Kurzrock received her MD from the University of Toronto, Canada. She has over 800 PubMed publications, an H-index of 122, has been named to the lists of most highly cited scientists in the world and the 25 world leaders in precision medicine, and she has a uniquely strong record of competitive funding with more than 100 million dollars in lifetime funding.


 Session Abstract – PMWC 2023 Silicon Valley

img-Jan. 25 - Track 3: Early Oncology Applications Track

Jan. 25 - Track 3: Early Oncology Applications Track
Track 3 - January 25 9.00 A.M.-4.45 P.M.


Track Chair: Hakan Sakul, Pfizer

  • PMWC Award Ceremony:
    Honoree: Todd Golub, Broad Institute
  • Fireside Chat: Precision Medicine: Past, Present and Future
    - Todd Golub, Broad Institute
    - Hakan Sakul, Pfizer
  • Challenges in Providing Global Access to Precision Health (PANEL)
    Chair: Mike Pellini, Section32
    - Peter Kuhn, USC
    - Steven Rosen
    - Sarah Hersey, BMS
    - Ed Abrahams, PMC
  • Regulatory and Reimbursement Challenges for Precision Medicines (PANEL)
    Chair: Cynthia Bens, PMC
    - Robert Dumanois, ThermoFisher
    - Kaska Kowanetz, Pfizer
    - Elaine Katrivanos, Tempus
    - Elizabeth Mansfield, Foundation Medicine
  • Early Cancer Detection 360 Degree View
    Chair: Christian Wolfrum, Siemens Healthineers
    - Stephan Brock, Molecular Health
    - Christian Eusemann, Siemens Healthineers
    - Costanzo DiPerna, CommonSpirit
  • Novel Clinical Trial Designs (PANEL)
    Chair: Razelle Kurzrock, Medical College of Wisconsin
    - Jason Sicklick, UCSD
    - Jim Palma, Target Cancer Foundation
    - Corrie Painter, Precede Bio
    - Laura J Esserman, UCSF
  • Equity in Delivery of Precision Cancer Care through Community-Academic Partnerships
    - Manali Patel, Stanford
  • Challenges in Genomic Profiling of Pediatric Cancers
    - Andrew Kung, MSK
    - Christina Curtis, Stanford
  • PMWC NCI Showcase
    - Solomon Diamond, Lodestone
    - Jennifer Smith, PreCyte
  • City of Hope Precision Medicine
    - Stephen Gruber, City of Hope
  • PMWC Showcase
    - Matthew Goldberg, Castle

 Session Abstract – PMWC 2023 Silicon Valley

img-Jan. 26 - Track 4: Clinical Utility of Liquid Biopsies Track

Jan. 26 - Track 4: Clinical Utility of Liquid Biopsies Track
Track 4 - January 26 9.00 A.M.-4.30 P.M.


Track Chair: Cindy Perettie, Roche

  • PMWC 2023 Award Ceremony
    - Luis Alberto Diaz Jr., MSK
    - Razelle Kurzrock, Medical College of Wisconsin
  • Non-invasive Liquid Biopsy Techniques (PANEL)
    Chair: Razelle Kurzrock, Medical College of Wisconsin
    - Apostolia Tsimberidou, MD Anderson
    - Mandana Kamgar, MD Medical College of Wisconsin
    - Mina Nikanjam, UCSD
    - Ash Alizadeh, Stanford University
  • Liquid Biopsy Challenges and Limitations (PANEL)
    Chair: Victor Lin, Mary Bird Perkins
    - Luis Alberto Diaz Jr., MSK
    - Maximilian Diehn, Stanford
    - Dana Dilbeck, Agilent
    - Emma Shtivelman, Cancer Commons
  • Liquid Biopsy in Clinical Trials: Learnings and COVID Experience (PANEL)
    Chair: Cindy Perettie, Roche Diagnostics
    - Eric Peters, Genenetch
    - Andrew Mckenzie, Sarah Cannon
    - Yang Pan, Gilead
    - Alan Sandler, Mirati Therapeutics
  • Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing
    Chair: Tom Beer, Exact Sceinces
  • Liquid Biopsy for Early Cancer Detection (PANEL)
    Chair: Priti Hegde, Foundation Medicine
    - Daniel Kim, UCSC
    - Mike Nolan, Freenome
    - Jeffrey Venstrom, Grail Bio
    - Kathryn Phillips, UCSF
    - Lon Castle, eviCore healthcare
    - Tom Beer, Exact Sciences
  • Liquid Biopsy for Minimal Residual Disease (PANEL)
    Chair: Minetta Liu, Natera
    - Peter Bach, Delfi diagnostics
    - Laura Vantveer, UCSF
    - Susan Bobulsky, Adaptive
    - Joshua Cohen, Johns Hopkins
  • PMWC Showcase
    - Harmeet Dhani, Biological Dynamics
    - Varsha Rao, Claret Bio
  • PMWC NCI Showcase
    - Xianghong Jasmine Zhou, EarlyDiagnostics